The effectiveness of mRNA vaccines has been confirmed during the COVID-19 pandemic. Now, mRNA platform technology is being applied to the development of "cancer vaccines," extending its potential beyond prevention to treatment.

Our CEO, Mr. Tae-jin Kang, will be contributing a series of five expert articles to the pharmaceutical and biotechnology media outlet "THEBIO," discussing how this technology is being utilized in the development of cancer vaccines, as well as the current trends and status of the technology.

Through this series, we expect readers to gain insights into the present and future of mRNA cancer vaccine technology.

Part 2 (Is defense important in soccer? Or is offense more important?) discusses which is more critical between preventive vaccines and therapeutic vaccines in 'overcoming and treating cancer'. What do you think is more important? For more details, please check the link below.